Company Data

FibroGen Inc

Ticker
FGEN
Current Price
$0.7059 -8.61%
Market Cap
$71.1M
Price Target
Refer to Report
Volume
9.4M
52wk Range
$0.18 - $2.8
Advanced Market Data

Overview

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen’s revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company’s ability to advance product candidates.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy